中国武汉新型冠状病毒肺炎患者风险预测工具的评估:单中心、回顾性、观察性研究
该单中心回顾性观察研究纳入2020年1月30日至3月14日武汉协和医院西院区673例连续成人COVID-19住院患者,收集入院时人口学、合并症、生命体征、意识状态、血氧饱和度及吸氧情况,计算NEWS、NEWS2、REMS、CRB-65和qSOFA评分。121例(18%)院内死亡。NEWS、NEWS2、REMS、CRB-65、qSOFA预测院内死亡的AUC(95%CI)分别为0.882(0.847-0.916)、0.880(0.845-0.914)、0.839(0.800-0.879)、0.766(0.718-0.814)、0.694(0.641-0.746)。NEWS中SpO2评分AUC为0.875(0.834-0.916),可独立预测院内死亡。作者结论认为NEWS/NEWS2区分度优于其他工具,但需多环境进一步验证。
要点
- 在673例住院COVID-19患者中,NEWS预测院内死亡AUC为0.882(95%CI 0.847-0.916),NEWS2为0.880(0.845-0.914),两者区分度均优于REMS、CRB-65和qSOFA。
- REMS的AUC为0.839(0.800-0.879),CRB-65为0.766(0.718-0.814),qSOFA为0.694(0.641-0.746),qSOFA区分度最低。
- NEWS中的SpO2评分是院内死亡最显著的预测因子,AUC为0.875(0.834-0.916),可独立预测院内死亡。
- 该研究为单中心回顾性观察研究,作者结论认为需多环境进一步验证NEWS/NEWS2在COVID-19中的适用性。
适用人群与场景
- 2020年1月30日至2020年3月14日武汉协和医院西院区(临时收治COVID-19重症患者的中心)连续收治的673例成人COVID-19住院患者,51%为男性,中位年龄61岁(IQR 50-69岁)。
研究设计与关键结果
- 研究类型为单中心、回顾性、观察性研究,纳入673例连续成人COVID-19住院患者,无干预。
- 院内死亡121例(18%)。
- 预测院内死亡的AUC(95%CI):NEWS 0.882(0.847-0.916),NEWS2 0.880(0.845-0.914),REMS 0.839(0.800-0.879),CRB-65 0.766(0.718-0.814),qSOFA 0.694(0.641-0.746)。
- NEWS参数中SpO2评分对院内死亡的预测最显著,AUC为0.875(95%CI 0.834-0.916)。
证据类型、等级与局限
- 证据类型:单中心、回顾性、观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,在住院COVID-19患者中NEWS/NEWS2对院内死亡的区分度优于REMS、CRB-65和qSOFA。
- 作者结论认为,外周血氧饱和度可独立预测此类患者院内死亡。
- 作者结论认为,需多环境进一步验证该发现以确定其在COVID-19中的适用性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate and compare the efficacy of National Early Warning Score, National Early Warning Score 2, Rapid Emergency Medicine Score, Confusion, Respiratory rate, Blood pressure, Age 65 score, and quick Sepsis-related Organ Failure Assessment on predicting in-hospital death in patients with coronavirus disease 2019.
DESIGN: A retrospective, observational study.
SETTING: Single center, West Campus of Wuhan Union hospital-a temporary center to manage critically ill patients with coronavirus disease 2019.
PATIENTS: A total of 673 consecutive adult patients with coronavirus disease 2019 between January 30, 2020, and March 14, 2020.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Data on demography, comorbidities, vital signs, mental status, oxygen saturation, and use of supplemental oxygen at admission to the ward were collected from medical records and used to score National Early Warning Score, National Early Warning Score 2, Rapid Emergency Medicine Score, Confusion, Respiratory rate, Blood pressure, Age 65 score, and quick Sepsis-related Organ Failure Assessment. Total number of patients was 673 (51% male) and median (interquartile range) age was 61 years (50-69 yr). One-hundred twenty-one patients died (18%). For predicting in-hospital death, the area under the receiver operating characteristics (95% CI) for National Early Warning Score, National Early Warning Score 2, Rapid Emergency Medicine Score, Confusion, Respiratory rate, Blood pressure, Age 65 score, and quick Sepsis-related Organ Failure Assessment were 0.882 (0.847-0.916), 0.880 (0.845-0.914), 0.839 (0.800-0.879), 0.766 (0.718-0.814), and 0.694 (0.641-0.746), respectively. Among the parameters of National Early Warning Score, the oxygen saturation score was found to be the most significant predictor of in-hospital death. The area under the receiver operating characteristic (95% CI) for oxygen saturation score was 0.875 (0.834-0.916).
CONCLUSIONS: In this single-center study, the discrimination of National Early Warning Score/National Early Warning Score 2 for predicting mortality in patients with coronavirus disease 2019 admitted to the ward was found to be superior to Rapid Emergency Medicine Score, Confusion, Respiratory rate, Blood pressure, Age 65 score, and quick Sepsis-related Organ Failure Assessment. Peripheral oxygen saturation could independently predict in-hospital death in these patients. Further validation of our finding in multiple settings is needed to determine its applicability for coronavirus disease 2019.
参考来源
- Liu FY, Sun XL, Zhang Y, et al. Evaluation of the Risk Prediction Tools for Patients With Coronavirus Disease 2019 in Wuhan, China: A Single-Centered, Retrospective, Observational Study. Crit Care Med. 2020. PMID: 32897668. doi:10.1097/CCM.0000000000004549
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。